TDF partners help us customize and execute each project to its fullest. We partner with various organizations and resources to help shape and advance our projects to their desired endpoints.

TIDO invites inquiries for partnerships and collaborations. Interested parties can contact Khadija Elabid, Program Coordinator, Technology Development Fund at technology.development@childrens.harvard.edu.

Technology Development Fund Advisory Board

Advisory Board Member Title and Organization
Joe Bolen, PhD Chief Scientific Officer at PureTech Health
Jerry Casey, MBA Independent Consultant
Former President and COO, Sekisui Diagnostics, LLC
Margaret Chu-Moyer, PhD Executive Director of Research, and Massachusetts Site Head, Amgen
Anthony J. Coyle, PhD CEO at Pandion Therapeutics
Alan Crane, MBA Venture Partner and Entrepreneur, Polaris Venture Partners
Skip Fleshman, MS Partner, Asset Management Ventures
Sandra Glucksman, PhD Entrepreneur In Residence at Third Rock Ventures
Keith Gottesdiener, MD CEO, Rhythm Pharmaceuticals, Inc.
Michael Magliochetti, MBA, PhD Operating Partner, Riverside Partners
Imran Nasrullah, MS, JD, CLP Director, Innovation Sourcing, Boehringer Ingelheim
Simon Read, PhD Chief Scientific Officer, Ra Pharma
Ken Rhodes, PhD Chief Scientific Officer, Yumanity Therapeutics
Craig Sorensen, PhD Independent Pharma Consultant
Former Vice President, External Research and Innovation, Vertex Pharmaceuticals Inc.
Beverly Teicher, PhD Chief, Molecular Pharmacology Branch, National Cancer Institute
Josh Tolkoff, MS Eng Managing Director, Ironwood Capital Management; Accelerator Executive, CIMIT
Stacie Weninger, PhD Executive Director, F-Prime Biomedical Research Initiative

Technology Development Fund Industry Partners